Search
On September 11, 2023, the U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) announced a settlement with LA Care related to potential violations of Health Insurance Portability and Accountability Act (HIPAA). LA Care is the largest publicly operated health plan in the...
In a Bloomberg article titled, “Cannabis Industry Enjoys a Rare Moment of Progress,” Partner Zachary Kobrin discussed the implications of last week’s news that the U.S. Department of Health and Human Services is recommending looser restrictions for cannabis producers. Kobrin, who is based in Fort...
In late August, the HHS Office for Civil Rights ("OCR") announced an $80,000 settlement with United Healthcare Insurance Company ("United") relating to OCR's right of access initiative (the "Initiative") which requires that patients be able to access their health information in a timely manner...
In a recent letter to the Drug Enforcement Administration (DEA), the Department of Health and Human Services (HHS) recommended that cannabis be reclassified as a Schedule III drug under the Controlled Substances Act. The DEA will conduct its own review of HHS’s findings before officially determining...
The HHS Office of Inspector General issued an 'unfavorable' advisory opinion in August with respect to a proposed joint venture relating to interoperative neuro monitoring. Parties considering joint ventures and those in joint ventures should review the OIG analysis to assess compliance with...
The Nuts and Bolts of Locums An introductory webinar on getting started in the independent practice of emergency medicine, including a discussion on five important details that are often missed when negotiating a locums contract: What is the “bill rate” for the client? What is the margin for the...
“When Congress removed hemp from the list of controlled substances and established a 0.3% limit on Delta-9 THC via the Agricultural Improvement Act of 2018, also known as the 2018 Farm Bill, it resulted in two somewhat unexpected product categories. The first was hemp-derived products, such as...
Financial services giant Mastercard banned the use of its debit cards for the purchase of state-legal cannabis. In an interview with Forbes, cannabis law attorney and partner Zack Kobrin says Mastercard’s actions are understandably motivated by the legal limbo that the cannabis industry exists in...
Zack Kobrin, cannabis law attorney and partner, tells The Recorder’s “Higher Law” that while Mastercard’s decision last week to ban the use of its debit cards in the state-legal purchase of marijuana is a blow to the cannabis industry, it will simply lead to new workarounds. “On a larger scale, yes...